Targeting Mitochondrial DNA repair for novel anti-cancer therapy (Q84259)

From EU Knowledge Graph
Revision as of 07:47, 18 February 2020 by DG Regio (talk | contribs) (‎Changed an Item: Label in wikidata changed)
Jump to navigation Jump to search
Project in Poland financed by DG Regio
Language Label Description Also known as
English
Targeting Mitochondrial DNA repair for novel anti-cancer therapy
Project in Poland financed by DG Regio

    Statements

    0 references
    3,200,000.0 zloty
    0 references
    768,000.0 Euro
    13 January 2020
    0 references
    3,200,000.0 zloty
    0 references
    768,000.0 Euro
    13 January 2020
    0 references
    100.0 percent
    0 references
    1 March 2018
    0 references
    28 February 2023
    0 references
    UNIWERSYTET GDAŃSKI
    0 references
    Mitochondrial DNA, partially associated with mitochondrial inner membrane, is at the heart of ROS production thus, relative to nuDNA, mtDNA contains high levels of oxidative damage. Many of these damages are mutagenic and cause disease. Located on the inner membrane, base excision repair pathway is a major defense mechanism against oxidative damage. EXOG, a membrane-bound 5'-exo/endonuclease, is crucial for mtDNA repair. Depletion of EXOG causes accumulation of DNA damage in the mitochondria, but not in the nucleus, increases oxidative stress and mitochondrial dysfunction and leads to cell death. We propose that N-terminal transmembrane domain of EXOG anchors BER repairosome to mitochondrial inner membrane and modulates crucial 5'exonuclease activity of the enzyme. Because preservation of mtDNA integrity in cancer cells is a key for cancer progression, we aim to develop inhibitors to specifically halt function of EXOG and increase sensitivity to traditional chemotherapeutics. (Polish)
    0 references

    Identifiers

    POIR.04.04.00-00-3E44/17
    0 references